• Aucun résultat trouvé

Seventy-two hours max

N/A
N/A
Protected

Academic year: 2022

Partager "Seventy-two hours max"

Copied!
1
0
0

Texte intégral

(1)

246

  Canadian Family PhysicianLe Médecin de famille canadien  Vol 54: february • féVrier 2008

FP Watch Surveillance médicale

Seventy-two hours max

Most people with Bell palsy will recover completely, but up to 30% of sufferers will have some remaining degree of facial disfigurement, pain, or psychologi- cal problems. Corticosteroids and antiviral agents are commonly prescribed for treatment within 72 hours of symptom onset. Do they work?

A large double-blind randomized placebo-controlled primary care study in Scotland looked at the efficacy of prednisolone or acyclovir in treating early Bell palsy.

Adults 16 years of age or older with unilateral idiopathic facial-nerve weakness who presented to emergency rooms or to primary care physicians were recruited into the study, as long as they could be assessed by a collab- orating otorhinolaryngologist within 72 hours of symp- tom onset. More than 550 patients were randomized into 4 treatment groups (placebo, prednisolone, acyclo- vir, or prednisolone and acyclovir) for 10 days of treat- ment. Final outcomes were available for 496 patients.

Baseline assessment was done shortly after ran- domization. Recovery was assessed at 3 months and again at 9 months if recovery was incomplete. Facial photographs were assessed independently by 3 experts using a standardized measure to determine the primary outcome of facial-nerve function. Secondary outcomes included health-related quality of life, facial appear- ance, and pain. Adverse events were also recorded. Pill containers (and unused pills) were collected.

Almost 65% of those treated with placebo were fully recovered at 3 months and 85% at 9 months. Treatment with prednisolone within 72 hours of symptom onset increased these rates to 83% at 3 months and almost 95% at 9 months. Acyclovir treatment alone was no better than placebo and there was no additional ben- efit when added to prednisolone. The number needed to treat to achieve 1 additional complete recovery was 6 at 3 months and 8 at 9 months. There were no clin- ically significant differences between the treatment groups in secondary outcomes and no serious adverse events in any group.

Source: Sullivan FM, Swan IRC, Donnan PT, Morrison JM, Smith BH, McKinstry B, et al. Early treatment with prednisolone or acyclovir in Bell’s palsy. N Engl J Med 2007;357(16):1598-607.

A nick of time?

One of the most common practices in obstetrics is amniotomy, the artificial rupture of the amniotic membranes during labour. It is thought that this practice speeds up contractions and thus labour.

But what is the evidence for this belief? Is this prac- tice safe for both the baby and the mother? Potential risks include umbilical cord prolapse, abnormal fetal heart tracings, and necessity for cesarean sec- tion delivery.

The Cochrane Collaboration recently published a systematic review to assess the effectiveness and safety of amniotomy in normally progressing sponta- neous labours and in spontaneous labours that had become prolonged.

The Cochrane Pregnancy and Childbirth’s Trials Register was searched for randomized controlled trials comparing amniotomy alone versus inten- tion to preserve the membranes; 14 trials were eligible for assessment. Almost 5000 women were involved in these trials. There was no consistency among the trials as to the timing of amniotomy (eg, cervical dilatation).

The researchers found no statistical difference in the length of the first stage of labour between the amniotomy and the intention-to-preserve-the-mem- brane groups. Maternal satisfaction with the child- birth experience was similar in both groups. There was no difference in low Apgar scores (< 7 at 5 min) between the 2 groups. Amniotomy was associated with increased risk of delivery by cesarean section, but this difference was not statistically significant.

None of the studies assessed the effect of amniot- omy on women’s pain in labour.

The authors conclude that routine amniotomy is not recommended for normally progressing labours or in labours that have become prolonged.

Source: Smyth RM, Alldred SK, Markham C. Amniotomy for shortening spontaneous labour. Cochrane Database Syst Rev 2007;(4):CD006167.

Clinical Shorts A brief review of the literature

Bottom line

Routine amniotomy does not appear to shorten the first stage of spontaneous labour.

Evidence does not support using amniotomy in normally progressing labours or in those that have become prolonged.

Bottom line

In Bell palsy, early treatment with prednisolone substantially improves the chances of complete recovery at 3 (NNT = 6) and 9 (NNT = 8) months.

There is no additional benefit to adding acyclovir to prednisolone.

Références

Documents relatifs

Estimates on stability over exponentially long times in the plane planetary problem. On the stability of realistic

Climator - Simuler les impacts du changement climatique pour mieux prévoir la vulnérabilité des forêts au changement climatique.. Que nous apprend la Recherche sur la vulnérabilité

Prospective validation of the Enhanced Liver Fibrosis test for the prediction of disease progression in a randomized trial of patients with primary sclerosing cholangitis.

A phase III double-blind placebo-controlled randomized study of dexamphetamine sulfate for fatigue in primary brain tumors patients: An ANOCEF trial (DXA).. Neuro-Oncology

In this study, although no complete tinea capitis cure occurred in the patients who were treated with topical squalamine, a statistically significantly higher hair- growth score

The primary outcome is all-cause mortality rate at Month 3; secondary objectives are to evaluate the efficacy of CYC compared to placebo on overall survival at Months 6 and

Celui du jour nouveau, Que l’aurore chante déjà tout haut,. Il s’échappe d’en haut, Et descend sur nous tel

AED: Antiepileptic drug; DSMB: Data and Safety Monitoring Board; EEG: Electroencephalogram; EKG: Electrocardiogram; EMU: Epilepsy monitoring unit; ENALEPSY: Efficacy of Naloxone